Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 1

Status

Recruiting 2Terminated 1Completed 1

Sponsor Class

INDUSTRY 6OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gynecologic 2Genitourinary 2

Conditions

Urinary Bladder Neoplasms 2Peritoneal Neoplasms 1Ovarian Neoplasms 1Neoplasms 1Ileus 1Fallopian Tube Neoplasms 1

Interventions

Cyclophosphamide 2064Radiotherapy 1984Cisplatin 1851Carboplatin 1557Gemcitabine 1452Paclitaxel 1320Bevacizumab 1316pembrolizumab 1235Docetaxel 1225Oxaliplatin 1181Capecitabine 1173Fluorouracil 1081Dexamethasone 979Magnetic Resonance Spectroscopy 967Nivolumab 936Rituximab 928Drug Therapy 911Surveys and Questionnaires 898Doxorubicin 845Etoposide 843Radiosurgery 814Blood Specimen Collection 814Irinotecan 783Cytarabine 743fludarabine 723Leucovorin 682Surgical Procedures, Operative 638Lenalidomide 618Biopsy 592fludarabine phosphate 568

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × alvimopan × Clear all
NCT06703476 2026-01-27

A Study of Surgical Techniques During Cystectomy

Memorial Sloan Kettering Cancer Center

Phase 3 Recruiting
530 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT03216525 2023-09-28

Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol

Brigham and Women's Hospital

Phase 3 Recruiting
136 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT03352414 2021-08-18

ILEUS

University of California, San Diego

Phase 2 Terminated
84 enrolled 10 charts
Gynecologic

Peritoneal Neoplasms, Ileus

NCT01704651 2016-10-24

Accelerating Gastrointestinal Recovery

Mayo Clinic

Phase 3 Completed
146 enrolled 11 charts
Gynecologic

Fallopian Tube Neoplasms, Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡